Market Cap 153.53B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.36
Forward PE 9.05
Profit Margin 12.42%
Debt to Equity Ratio 0.75
Volume 58,079,000
Avg Vol 37,747,348
Day's Range N/A - N/A
Shares Out 5.69B
Stochastic %K 10%
Beta 0.43
Analysts Sell
Price Target $29.02

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
Willieberich
Willieberich Apr. 29 at 4:16 PM
$PFE just another gift for me to buy...
0 · Reply
Micheal_Pothead
Micheal_Pothead Apr. 29 at 4:08 PM
$PFE lmfao Sandisk is worth more than us now
1 · Reply
Pfizer
Pfizer Apr. 29 at 3:22 PM
$PFE Pfizer today announced positive topline results from the Phase 3 MagnetisMM-5 study evaluating ELREXFIO® (elranatamab) as monotherapy in adults with relapsed or refractory multiple myeloma (RRMM) who received at least one prior line of treatment. These data will be discussed with global health authorities, and detailed results from MagnetisMM-5 will be submitted for presentation at a future medical congress. Read more: https://investors.pfizer.com/Investors/news-events/News/news-details/2026/Pfizers-ELREXFIO-Significantly-Improves-Progression-Free-Survival-for-Double-Class-Exposed-Patients-with-Relapsed-or-Refractory-Multiple-Myeloma/default.aspx
0 · Reply
TradeMachinist
TradeMachinist Apr. 29 at 3:22 PM
$NTLA's gene-editing thesis faces a sobering reality check: by commercialization, oral small molecules and generics may erode the addressable market. Moat erosion risk is non-trivial when payers favor cheaper modalities. Versus established cash generators like $PFE or $CVS, NTLA's FCF yield remains deeply negative with binary clinical readouts gating any rerating. Eyes wide open required.
0 · Reply
Linhrx
Linhrx Apr. 29 at 3:02 PM
$PFE dividend is more than a week away. Catching a trade wind while I’m sleeping 😴🍻🤓
0 · Reply
1hawk
1hawk Apr. 29 at 2:59 PM
$PFE averaging down
0 · Reply
Micheal_Pothead
Micheal_Pothead Apr. 29 at 2:47 PM
$PFE most stocks get a pre-divy run up… PFE gets a pre divy sell off
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Apr. 29 at 2:44 PM
$PFE The dividend will come and carry our troubles away
0 · Reply
Micheal_Pothead
Micheal_Pothead Apr. 29 at 2:31 PM
$PFE Intel is now worth 3 Pfizer’s and doesn’t make a profit 🤡🤡🤡
1 · Reply
Micheal_Pothead
Micheal_Pothead Apr. 29 at 2:28 PM
$PFE they officially killed the breakout, it never ends with this shit
0 · Reply
Latest News on PFE
Pfizer's blood cancer drug meets main goal in late-stage trial

Apr 29, 2026, 7:42 AM EDT - 4 hours ago

Pfizer's blood cancer drug meets main goal in late-stage trial


Pfizer Stock Is Declining Today: What's Happening?

Apr 28, 2026, 1:23 PM EDT - 23 hours ago

Pfizer Stock Is Declining Today: What's Happening?


Pfizer Reaches Three Settlement Agreements for VYNDAMAX

Apr 28, 2026, 10:17 AM EDT - 1 day ago

Pfizer Reaches Three Settlement Agreements for VYNDAMAX


Pfizer Transcript: AGM 2026

Apr 23, 2026, 9:00 AM EDT - 6 days ago

Pfizer Transcript: AGM 2026


Pfizer Declares Second-Quarter 2026 Dividend

Apr 22, 2026, 4:45 PM EDT - 6 days ago

Pfizer Declares Second-Quarter 2026 Dividend


The Big 3: PFE, V, SYF

Apr 16, 2026, 1:01 PM EDT - 12 days ago

The Big 3: PFE, V, SYF

SYF V


Big Pharma Is Turning to China for the Newest Drug Ideas

Apr 10, 2026, 11:00 PM EDT - 18 days ago

Big Pharma Is Turning to China for the Newest Drug Ideas


Why Is Pfizer Stock Dropping Tuesday?

Apr 7, 2026, 1:54 PM EDT - 21 days ago

Why Is Pfizer Stock Dropping Tuesday?


5 ‘Healthy' Dividends Paying Up To 14.1%

Mar 22, 2026, 9:45 AM EDT - 5 weeks ago

5 ‘Healthy' Dividends Paying Up To 14.1%

ARE BME DOC HQH


China approves Pfizer GLP-1 drug for weight management

Mar 6, 2026, 12:40 AM EST - 7 weeks ago

China approves Pfizer GLP-1 drug for weight management


Pfizer CEO flags issues with FDA's vaccine leadership

Mar 2, 2026, 11:14 AM EST - 2 months ago

Pfizer CEO flags issues with FDA's vaccine leadership


Pfizer Transcript: TD Cowen 46th Annual Health Care Conference

Mar 2, 2026, 10:30 AM EST - 2 months ago

Pfizer Transcript: TD Cowen 46th Annual Health Care Conference


Pfizer Adds Sciwind As China Partner For New Weight Loss Drug

Feb 24, 2026, 7:45 AM EST - 2 months ago

Pfizer Adds Sciwind As China Partner For New Weight Loss Drug


Pfizer in diabetes drug deal with Sciwind Biosciences

Feb 23, 2026, 10:26 PM EST - 2 months ago

Pfizer in diabetes drug deal with Sciwind Biosciences


Is There 25% Downside For Pfizer Stock?

Feb 18, 2026, 12:00 PM EST - 2 months ago

Is There 25% Downside For Pfizer Stock?


Pfizer Earnings Call Transcript: Q4 2025

Feb 3, 2026, 10:00 AM EST - 3 months ago

Pfizer Earnings Call Transcript: Q4 2025


Pfizer Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 12:45 PM EST - 3 months ago

Pfizer Transcript: 44th Annual J.P. Morgan Healthcare Conference


Pfizer Transcript: Guidance

Dec 16, 2025, 8:00 AM EST - 4 months ago

Pfizer Transcript: Guidance


Pfizer Transcript: Jefferies London Healthcare Conference 2025

Nov 19, 2025, 4:00 AM EST - 5 months ago

Pfizer Transcript: Jefferies London Healthcare Conference 2025


Pfizer Transcript: Status Update

Nov 10, 2025, 8:30 AM EST - 6 months ago

Pfizer Transcript: Status Update


Pfizer Earnings Call Transcript: Q3 2025

Nov 4, 2025, 10:00 AM EST - 6 months ago

Pfizer Earnings Call Transcript: Q3 2025


Pfizer Transcript: M&A Announcement

Sep 22, 2025, 8:00 AM EDT - 7 months ago

Pfizer Transcript: M&A Announcement


Pfizer Earnings Call Transcript: Q2 2025

Aug 5, 2025, 10:00 AM EDT - 9 months ago

Pfizer Earnings Call Transcript: Q2 2025


Pfizer Earnings Call Transcript: Q1 2025

Apr 29, 2025, 10:00 AM EDT - 1 year ago

Pfizer Earnings Call Transcript: Q1 2025


Pfizer Transcript: AGM 2025

Apr 24, 2025, 9:00 AM EDT - 1 year ago

Pfizer Transcript: AGM 2025


Pfizer Transcript: TD Cowen 45th Annual Healthcare Conference

Mar 3, 2025, 10:30 AM EST - 1 year ago

Pfizer Transcript: TD Cowen 45th Annual Healthcare Conference


Pfizer Transcript: Status Update

Feb 27, 2025, 10:00 AM EST - 1 year ago

Pfizer Transcript: Status Update


Pfizer Earnings Call Transcript: Q4 2024

Feb 4, 2025, 10:30 AM EST - 1 year ago

Pfizer Earnings Call Transcript: Q4 2024


Pfizer Transcript: Status Update

Dec 18, 2024, 10:00 AM EST - 1 year ago

Pfizer Transcript: Status Update


Pfizer Transcript: Guidance

Dec 17, 2024, 8:30 AM EST - 1 year ago

Pfizer Transcript: Guidance


Pfizer Transcript: UBS Global Healthcare Conference 2024

Nov 13, 2024, 3:30 PM EST - 1 year ago

Pfizer Transcript: UBS Global Healthcare Conference 2024


Pfizer Earnings Call Transcript: Q3 2024

Oct 29, 2024, 10:00 AM EDT - 1 year ago

Pfizer Earnings Call Transcript: Q3 2024


Pfizer Earnings Call Transcript: Q2 2024

Jul 30, 2024, 10:30 AM EDT - 1 year ago

Pfizer Earnings Call Transcript: Q2 2024


Pfizer Earnings Call Transcript: Q1 2024

May 1, 2024, 10:00 AM EDT - 2 years ago

Pfizer Earnings Call Transcript: Q1 2024


Pfizer Transcript: AGM 2024

Apr 25, 2024, 9:00 AM EDT - 2 years ago

Pfizer Transcript: AGM 2024


Pfizer Transcript: Oncology Innovation Day

Feb 29, 2024, 1:00 PM EST - 2 years ago

Pfizer Transcript: Oncology Innovation Day


Pfizer Earnings Call Transcript: Q4 2023

Jan 30, 2024, 10:00 AM EST - 2 years ago

Pfizer Earnings Call Transcript: Q4 2023


Pfizer Transcript: Investor Update

Dec 13, 2023, 8:30 AM EST - 2 years ago

Pfizer Transcript: Investor Update


Pfizer Earnings Call Transcript: Q3 2023

Oct 31, 2023, 10:00 AM EDT - 2 years ago

Pfizer Earnings Call Transcript: Q3 2023


Pfizer Transcript: Investor Update

Oct 16, 2023, 8:00 AM EDT - 2 years ago

Pfizer Transcript: Investor Update


Pfizer Transcript: Citi’s 18th Annual BioPharma Conference

Sep 7, 2023, 10:30 AM EDT - 2 years ago

Pfizer Transcript: Citi’s 18th Annual BioPharma Conference


Pfizer Earnings Call Transcript: Q2 2023

Aug 1, 2023, 10:00 AM EDT - 2 years ago

Pfizer Earnings Call Transcript: Q2 2023


Pfizer Earnings Call Transcript: Q1 2023

May 2, 2023, 10:00 AM EDT - 3 years ago

Pfizer Earnings Call Transcript: Q1 2023


Pfizer Transcript: M&A Announcement

Mar 13, 2023, 8:00 AM EDT - 3 years ago

Pfizer Transcript: M&A Announcement


Pfizer Transcript: Cowen Health Care Conference

Mar 7, 2023, 10:30 AM EST - 3 years ago

Pfizer Transcript: Cowen Health Care Conference


Pfizer Transcript: SVB Securities Global Biopharma Conference

Feb 16, 2023, 10:00 AM EST - 3 years ago

Pfizer Transcript: SVB Securities Global Biopharma Conference


Pfizer Earnings Call Transcript: Q4 2022

Jan 31, 2023, 10:00 AM EST - 3 years ago

Pfizer Earnings Call Transcript: Q4 2022


Pfizer Transcript: JPMorgan Healthcare Conference

Jan 9, 2023, 6:00 PM EST - 3 years ago

Pfizer Transcript: JPMorgan Healthcare Conference


Pfizer Earnings Call Transcript: Q3 2022

Nov 1, 2022, 10:00 AM EDT - 3 years ago

Pfizer Earnings Call Transcript: Q3 2022


Pfizer Transcript: Status Update

Oct 20, 2022, 6:48 AM EDT - 3 years ago

Pfizer Transcript: Status Update


Pfizer Transcript: Fireside Chat

Sep 26, 2022, 4:32 AM EDT - 3 years ago

Pfizer Transcript: Fireside Chat


Pfizer Transcript: Status Update

Sep 21, 2022, 8:00 AM EDT - 3 years ago

Pfizer Transcript: Status Update


Pfizer Earnings Call Transcript: Q2 2022

Jul 27, 2022, 8:27 PM EDT - 4 years ago

Pfizer Earnings Call Transcript: Q2 2022


Pfizer Transcript: M&A Announcement

May 10, 2022, 7:11 AM EDT - 4 years ago

Pfizer Transcript: M&A Announcement


Pfizer Earnings Call Transcript: Q1 2022

May 3, 2022, 6:52 AM EDT - 4 years ago

Pfizer Earnings Call Transcript: Q1 2022


Pfizer Earnings Call Transcript: Q4 2021

Feb 8, 2022, 4:39 AM EST - 4 years ago

Pfizer Earnings Call Transcript: Q4 2021


Pfizer Transcript: Investor Call

Dec 16, 2021, 7:00 PM EST - 4 years ago

Pfizer Transcript: Investor Call


Pfizer Transcript: M&A Announcement

Dec 12, 2021, 7:00 PM EST - 4 years ago

Pfizer Transcript: M&A Announcement


Pfizer Earnings Call Transcript: Q3 2021

Nov 1, 2021, 8:00 PM EDT - 4 years ago

Pfizer Earnings Call Transcript: Q3 2021


Pfizer Earnings Call Transcript: Q2 2021

Jul 28, 2021, 2:22 AM EDT - 5 years ago

Pfizer Earnings Call Transcript: Q2 2021


Pfizer Earnings Call Transcript: Q1 2021

May 4, 2021, 10:05 AM EDT - 5 years ago

Pfizer Earnings Call Transcript: Q1 2021


Pfizer Transcript: AGM 2021

Apr 21, 2021, 8:25 PM EDT - 5 years ago

Pfizer Transcript: AGM 2021


Pfizer Transcript: Investor & Analyst Day 2021

Apr 8, 2021, 8:37 PM EDT - 5 years ago

Pfizer Transcript: Investor & Analyst Day 2021


Pfizer Earnings Call Transcript: Q4 2020

Feb 1, 2021, 8:47 PM EST - 5 years ago

Pfizer Earnings Call Transcript: Q4 2020


Pfizer Earnings Call Transcript: Q3 2020

Oct 26, 2020, 10:00 PM EDT - 5 years ago

Pfizer Earnings Call Transcript: Q3 2020


Pfizer Transcript: Investor Day Part 2 2020

Sep 14, 2020, 9:10 PM EDT - 6 years ago

Pfizer Transcript: Investor Day Part 2 2020


Pfizer Transcript: Investor Day Part 1 2020

Sep 13, 2020, 9:05 PM EDT - 6 years ago

Pfizer Transcript: Investor Day Part 1 2020


Pfizer Earnings Call Transcript: Q2 2020

Jul 27, 2020, 9:17 PM EDT - 6 years ago

Pfizer Earnings Call Transcript: Q2 2020


Pfizer Transcript: Analyst & Investor Call

Jun 30, 2020, 9:21 PM EDT - 6 years ago

Pfizer Transcript: Analyst & Investor Call


Pfizer Transcript: Analyst & Investor Call

Jun 17, 2020, 9:38 PM EDT - 6 years ago

Pfizer Transcript: Analyst & Investor Call


Pfizer Transcript: Analyst & Investor Call

May 14, 2020, 9:48 PM EDT - 6 years ago

Pfizer Transcript: Analyst & Investor Call


Pfizer Earnings Call Transcript: Q1 2020

Apr 27, 2020, 9:55 PM EDT - 6 years ago

Pfizer Earnings Call Transcript: Q1 2020


Pfizer Transcript: AGM 2020

Apr 22, 2020, 10:06 PM EDT - 6 years ago

Pfizer Transcript: AGM 2020


Pfizer Earnings Call Transcript: Q4 2019

Jan 27, 2020, 10:09 PM EST - 6 years ago

Pfizer Earnings Call Transcript: Q4 2019


Pfizer Earnings Call Transcript: Q3 2019

Oct 28, 2019, 11:16 PM EDT - 7 years ago

Pfizer Earnings Call Transcript: Q3 2019


Pfizer Earnings Call Transcript: Q2 2019

Jul 28, 2019, 10:20 PM EDT - 7 years ago

Pfizer Earnings Call Transcript: Q2 2019


Pfizer Transcript: M&A Announcement

Jun 16, 2019, 10:23 PM EDT - 7 years ago

Pfizer Transcript: M&A Announcement


Pfizer Earnings Call Transcript: Q1 2019

Apr 29, 2019, 10:27 PM EDT - 7 years ago

Pfizer Earnings Call Transcript: Q1 2019


Pfizer Transcript: Analyst Day 2019

Apr 24, 2019, 10:35 PM EDT - 7 years ago

Pfizer Transcript: Analyst Day 2019


Pfizer Earnings Call Transcript: Q4 2018

Jan 28, 2019, 10:41 PM EST - 7 years ago

Pfizer Earnings Call Transcript: Q4 2018


Willieberich
Willieberich Apr. 29 at 4:16 PM
$PFE just another gift for me to buy...
0 · Reply
Micheal_Pothead
Micheal_Pothead Apr. 29 at 4:08 PM
$PFE lmfao Sandisk is worth more than us now
1 · Reply
Pfizer
Pfizer Apr. 29 at 3:22 PM
$PFE Pfizer today announced positive topline results from the Phase 3 MagnetisMM-5 study evaluating ELREXFIO® (elranatamab) as monotherapy in adults with relapsed or refractory multiple myeloma (RRMM) who received at least one prior line of treatment. These data will be discussed with global health authorities, and detailed results from MagnetisMM-5 will be submitted for presentation at a future medical congress. Read more: https://investors.pfizer.com/Investors/news-events/News/news-details/2026/Pfizers-ELREXFIO-Significantly-Improves-Progression-Free-Survival-for-Double-Class-Exposed-Patients-with-Relapsed-or-Refractory-Multiple-Myeloma/default.aspx
0 · Reply
TradeMachinist
TradeMachinist Apr. 29 at 3:22 PM
$NTLA's gene-editing thesis faces a sobering reality check: by commercialization, oral small molecules and generics may erode the addressable market. Moat erosion risk is non-trivial when payers favor cheaper modalities. Versus established cash generators like $PFE or $CVS, NTLA's FCF yield remains deeply negative with binary clinical readouts gating any rerating. Eyes wide open required.
0 · Reply
Linhrx
Linhrx Apr. 29 at 3:02 PM
$PFE dividend is more than a week away. Catching a trade wind while I’m sleeping 😴🍻🤓
0 · Reply
1hawk
1hawk Apr. 29 at 2:59 PM
$PFE averaging down
0 · Reply
Micheal_Pothead
Micheal_Pothead Apr. 29 at 2:47 PM
$PFE most stocks get a pre-divy run up… PFE gets a pre divy sell off
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Apr. 29 at 2:44 PM
$PFE The dividend will come and carry our troubles away
0 · Reply
Micheal_Pothead
Micheal_Pothead Apr. 29 at 2:31 PM
$PFE Intel is now worth 3 Pfizer’s and doesn’t make a profit 🤡🤡🤡
1 · Reply
Micheal_Pothead
Micheal_Pothead Apr. 29 at 2:28 PM
$PFE they officially killed the breakout, it never ends with this shit
0 · Reply
Linhrx
Linhrx Apr. 29 at 2:27 PM
$PFE slowly build a position here ✅🍻
0 · Reply
focafoca99
focafoca99 Apr. 29 at 2:23 PM
$PFE said ELREXFIO significantly improved progression-free survival in double-class exposed patients with relapsed or refractory multiple myeloma. https://www.rapidticker.com/news/pfe-pfizers-elrexfio-significantly-improves-progression-663c
0 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Apr. 29 at 2:23 PM
0 · Reply
Willieberich
Willieberich Apr. 29 at 2:21 PM
$PFE buying
0 · Reply
Sjs360
Sjs360 Apr. 29 at 2:19 PM
$SMCI $TTD $PFE i hate these stocks so much
0 · Reply
Micheal_Pothead
Micheal_Pothead Apr. 29 at 2:17 PM
$PFE what a dog
0 · Reply
Micheal_Pothead
Micheal_Pothead Apr. 29 at 1:47 PM
$PFE they literally short it every time it goes green
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Apr. 29 at 1:42 PM
$PFE If anyone wants to know what purgatory is like, buy Pfizer. The official stock of purgatory.
1 · Reply
Micheal_Pothead
Micheal_Pothead Apr. 29 at 1:31 PM
$PFE yeah go down more why not
0 · Reply
TheUnmaker
TheUnmaker Apr. 29 at 1:12 PM
$TNXP This article is a few months old but it puts Lymes Disease fight in the eyes of the HHS and with Tonix new Lymes disease vaccine slated for near FDA approval, I believe the odds are in the favors of believers. https://www.hhs.gov/press-room/secretary-kennedy-convenes-lyme-disease-patients-providers-announce-new-diagnostic-efforts.html $PFE $LLY $JNJ
0 · Reply
MrPeanutEsquire
MrPeanutEsquire Apr. 29 at 1:12 PM
$PFE I hope this good news doesn't take us down too much today
0 · Reply
pasuny
pasuny Apr. 29 at 1:09 PM
$PFE Stupid junk garbage trash
0 · Reply